- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Eastman Announces 2025 Financial Results
Chemical company reports lower sales revenue but strong cash flow generation.
Jan. 29, 2026 at 6:39pm
Got story updates? Submit your updates here. ›
Eastman Chemical Co. announced its financial results for the fourth quarter and full year 2025, with sales revenue decreasing by 12% in Q4 and 7% for the full year compared to 2024. The company saw a $285 million decrease in net earnings before interest and taxes, which it attributed to lower sales volume/mix and unfavorable price-cost factors, partially offset by cost reduction initiatives and lower variable compensation expense. However, Eastman generated operating cash flow approaching $1 billion in 2025, and the company plans to increase its cost structure reduction actions in 2026.
Why it matters
Eastman's financial results provide insight into the performance of the broader chemical industry, which has faced challenges from lower consumer demand and rising costs. The company's ability to generate strong cash flow despite these headwinds demonstrates the strength of its portfolio and disciplined approach to cost management.
The details
Eastman's sales revenue decreased by 12% in Q4 2025 compared to the prior year quarter, and by 7% for the full year 2025 versus 2024. The company attributed these declines to lower sales volume/mix and lower selling prices. Net earnings before interest and taxes (EBIT) fell by $285 million in Q4 2025 compared to the prior year quarter, due to the lower sales volume/mix and unfavorable price-cost factors, partially offset by cost reduction initiatives and lower variable compensation expense. However, Eastman generated operating cash flow approaching $1 billion in 2025, which the company said validates its disciplined approach to cost and working capital management.
- Eastman announced its Q4 2025 and full year 2025 financial results on January 29, 2026.
- The company's Kingsport, Tennessee methanolysis facility reached its operational goals in 2025, producing more than 2.5 times the recycled content versus 2024 and delivering approximately $60 million in incremental earnings.
The players
Eastman Chemical Co.
A global specialty materials company that produces a wide range of advanced materials, chemicals, and fibers for consumer and industrial markets.
Mark Costa
Eastman's board chair and CEO, who commented on the company's 2025 performance and outlook.
What they’re saying
“Despite a challenging operating environment for the chemical industry and continued weakness in consumer discretionary end markets, our team delivered a year that demonstrates the strength of our portfolio's ability to generate cash.”
— Mark Costa, Board Chair and CEO, Eastman Chemical Co.
“In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management.”
— Mark Costa, Board Chair and CEO, Eastman Chemical Co.
What’s next
Eastman plans to increase its cost structure reduction actions to $125 to $150 million in 2026, building on previous changes. The company expects its 2026 operating cash flow to be similar to 2025 levels.
The takeaway
Eastman's ability to generate strong cash flow in a challenging operating environment for the chemical industry demonstrates the resilience of its portfolio and disciplined approach to cost management. The company's focus on reducing costs and improving its competitiveness positions it well to capture recovery-driven upside when market conditions improve.

